By Robert Preidt
FRIDAY, Dec. 18, 2020 (HealthDay Information) — There isn’t any proof of a hyperlink between COVID-19 and a critical neurological situation known as Guillain-Barré syndrome, British researchers say.
Guillain-Barré syndrome is a uncommon autoimmune situation that assaults the peripheral nervous system, usually inflicting numbness, weak point and ache. In extreme instances, it may well trigger paralysis and is typically deadly.
The precise trigger is not identified, however the syndrome usually happens after a gastroenteritis an infection known as Camplylobacter, with the immune system mistakenly attacking nerves as a substitute of germs.
Earlier analysis discovered a rise in instances of Guillain-Barré syndrome throughout Zika virus outbreaks in Latin America, and a few research have raised concern a couple of doable hyperlink between COVID-19 an infection and the syndrome.
For the brand new research, researchers from College Faculty London in contrast instances of Guillain-Barré in the UK between 2016 and 2019 to these through the coronavirus pandemic within the first half of 2020.
The annual incidence of sufferers with Guillain-Barré who had been handled in hospitals between 2016 and 2019 topped out at 1.88 per 100,000 folks. Between March and Might 2020, it was 40% to 50% decrease than in the identical months of 2016 to 2019, in accordance with the research revealed Dec. 14 within the journal Mind.
The authors mentioned their findings contradict these of smaller research and will reassure folks.
“The potential of SARS-CoV-2 driving a worldwide spike in GBS has been eagerly monitored with plenty of revealed small case sequence already asserting a causal hyperlink,” mentioned first creator Stephen Keddie of the Division of Neuromuscular Illness.
“Our epidemiological research reveals there was no elevated incidence in GBS through the first wave of COVID-19; slightly, there was a lower and due to this fact no causal hyperlink of COVID-19 to GBS may be made,” he mentioned in a college information launch.
The U.S. Nationwide Institute of Neurological Issues and Stroke has extra on Guillain-Barré syndrome.
SOURCE: College Faculty London, information launch, Dec. 13, 2020